The 3 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +173.97% increase from the last price of 2.19.
The current consensus among 4 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since December, when it was upgraded from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.56
Reporting Date Feb 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.